The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations

2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations

March 1, 2015 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Guidelines

BOSTON—Guidelines for the management of rheumatoid arthritis (RA) always spark interest and debate among rheumatologists. A recent glimpse at a draft of the new recommendations for RA treatment was no exception.

You Might Also Like
  • 2013 ACR/ARHP Annual Meeting: The Rheumatoid Arthritis Treatment Debate
  • 2014 ACR/ARHP Annual Meeting: New Directions for Gout
  • 2014 ACR/ARHP Annual Meeting: Diagnosis, Management of Sarcoidosis in the Heart, Central Nervous System
Explore This Issue
March 2015
Also By This Author
  • Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD

On Nov. 16, 2014, in Boston, attendees at the ACR/ARHP Annual Meeting packed a large auditorium, even sitting on the floor in front of the panelists’ table, to read and discuss New ACR Recommendations for the Management of Rheumatoid Arthritis (RA).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Guideline development group members presented a thorough explanation of techniques for gathering and measuring the value of scientific evidence to support the development of treatment recommendations. They also shared a first look at the in-progress guidelines, including emerging approaches to treatment during RA flares and the use of live vaccines in RA patients currently taking biologics. The final guidelines will be jointly published in Arthritis & Rheumatology and Arthritis Care & Research in summer 2015. Since the last RA guidelines update in 2012, new RA therapies, such as tofacitinib, have been approved, driving the need for an update.

GRADE: A Paradigm Shift

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. McAlindon
Dr. McAlindon

The guideline development group began the update project in December 2013. The process used represents a paradigm shift in the approach the ACR uses to develop guidelines, said Timothy McAlindon, MD, MPH, professor of medicine at Tufts University School of Medicine in Boston.

Past ACR RA management guidelines and updates, including those published in 2008 and 2012, used the RAND/UCLA methodology to gather, measure and filter evidence to support recommendations. “But even the RAND/UCLA approach lacked transparency,” he said. For the upcoming 2015 RA guideline, the ACR used GRADE methodology, which incorporates a more “transparent, granular literature review,” he said. GRADE, which stands for Grading of Recommendations, Assessment, Development and Evaluation, incorporates considerations of the quality of evidence, sample sizes, effect sizes and the type of study used. Recommendations may be labeled as strong or conditional depending on these factors, he said.

One of the most important parts of the process in forming the upcoming management recommendations was the development of PICO (population, intervention, comparators, outcomes) questions focusing on RA management issues and treatment approaches, Dr. McAlindon said. Development group members began by generating questions reflecting important clinical scenarios in RA treatment and defining outcomes related to those scenarios. They then gathered and systematically reviewed the available evidence on those topics/outcomes, and subsequently rated the quality of the evidence across outcomes, for each clinical question. The next step was to ask a panel to consider the evidence in light of their own experience and expertise, and draft recommendation statements that could be included in the final guideline. The next step will be to write the guideline paper and submit it to the journals and ACR for approval.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: ACR/ARHP Annual Meeting, Bernstein, Drugs, Management, Rheumatoid arthritis, rheumatology, TreatmentIssue: March 2015

You Might Also Like:
  • 2013 ACR/ARHP Annual Meeting: The Rheumatoid Arthritis Treatment Debate
  • 2014 ACR/ARHP Annual Meeting: New Directions for Gout
  • 2014 ACR/ARHP Annual Meeting: Diagnosis, Management of Sarcoidosis in the Heart, Central Nervous System
  • 2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)